TNFRSF18 and neoplasm: Interestingly, many of the top 10 most frequent clones in the IgG and CTX plus IgG groups were Foxp3+ Tregs, indicating that an important role of anti-GITR therapy is eliminating the tumor- and CTX-associated expansion of Tregs.